Variable | Univariate | Multivariate | ||
---|---|---|---|---|
HR (95% CI) | p value | Adjusted HR (95% CI) | p value | |
HGI group | < 0.001 | 0.012 | ||
Q5 | Ref. | Ref. | Ref. | Ref. |
Q4 | 0.864 (0.778, 0.960) | 0.007 | 0.889 (0.799, 0.989) | 0.030 |
Q3 | 0.789 (0.708, 0.878) | < 0.001 | 0.861 (0.771, 0.960) | 0.007 |
Q2 | 0.746 (0.670, 0.831) | < 0.001 | 0.835 (0.747, 0.932) | 0.001 |
Q1 | 0.858 (0.773, 0.952) | 0.004 | 0.929 (0.833, 1.035) | 0.173 |
Age, years | 1.020 (1.017, 1.024) | < 0.001 | 1.011 (1.006, 1.016) | < 0.001 |
Male gender | 0.985 (0.917, 1.058) | 0.686 | ||
Medical history | ||||
Current/ex-Smoker | 1.018 (0.950, 1.090) | 0.614 | ||
Hypertension | 1.239 (1.146, 1.339) | < 0.001 | 1.109 (1.022, 1.204) | 0.013 |
Diabetes | 1.309 (1.222, 1.403) | < 0.001 | ||
Dyslipidemia | 0.972 (0.907, 1.041) | 0.415 | ||
Previous Stroke | 1.375 (1.265, 1.495) | < 0.001 | 1.208 (1.109, 1.317) | < 0.001 |
Previous MI | 1.369 (1.239, 1.512) | < 0.001 | ||
Past PCI | 1.372 (1.256, 1.499) | < 0.001 | 1.268 (1.157, 1.389) | < 0.001 |
Past CABG | 1.232 (1.005, 1.511) | 0.045 | ||
Physical examination | ||||
BMI, kg/m2 | 0.984 (0.975, 0.994) | 0.001 | 0.987 (0.977, 0.997) | 0.012 |
SBP, mmHg | 1.003 (1.002, 1.005) | < 0.001 | ||
DBP, mmHg | 0.996 (0.993, 0.999) | 0.01 | ||
Heart rate, bpm | 1.008 (1.005, 1.010) | < 0.001 | 1.004 (1.002, 1.007) | 0.001 |
Clinical presentation | ||||
STEMI | 1.042 (0.954, 1.139) | 0.357 | ||
NSTEMI | 1.407 (1.295, 1.530) | < 0.001 | 1.205 (1.068, 1.358) | < 0.001 |
UAP | 0.779 (0.726, 0.835) | < 0.001 | ||
Medication on admission | ||||
Antiplatelet agent | 1.070 (0.998, 1.148) | 0.057 | ||
ACEI/ARB | 1.107 (1.031, 1.189) | 0.005 | ||
Beta-blocker | 0.989 (0.911, 1.073) | 0.783 | ||
Statins | 0.983 (0.912, 1.059) | 0.649 | ||
Laboratory data | ||||
WBC, 109/L | 1.024 (1.010, 1.037) | 0.001 | 1.020 (1.004, 1.036) | 0.008 |
Hemoglobin, g/L | 0.992 (0.990, 0.994) | < 0.001 | ||
Hs-CRP, mg/L | 1.013 (1.010, 1.016) | < 0.001 | ||
RBG at admission, mmol/L | 1.023 (1.014, 1.032) | < 0.001 | ||
FPG, mmol/L | 1.048 (1.034, 1.062) | < 0.001 | ||
HbA1c,% | 1.077 (1.053, 1.102) | < 0.001 | ||
Albumin, g/L | 0.954 (0.946, 0.962) | < 0.001 | ||
Creatinine, umol/L | 1.002 (1.001, 1.002) | < 0.001 | ||
eGFR, ml/min/1.73m2 | 0.988 (0.987, 0.990) | < 0.001 | 0.993 (0.991, 0.995) | < 0.001 |
TC, mmol/L | 0.949 (0.918, 0.982) | 0.002 | ||
TGs, mmol/L | 0.986 (0.958, 1.016) | 0.361 | ||
LDL-C, mmol/L | 0.952 (0.909, 0.997) | 0.035 | ||
HDL-C, mmol/L | 0.745 (0.653, 0.850) | < 0.001 | 0.809 (0.681, 0.962) | 0.002 |
Echocardiography | ||||
LVEF | 0.107 (0.076, 0.148) | < 0.001 | 0.240 (0.167, 0.346) | < 0.001 |
Angiography findings | ||||
LM/three-vessel | 1.233 (1.150, 1.321) | < 0.001 | 1.208 (1.117, 1.307) | < 0.001 |
Proximal LAD | 0.917 (0.855, 0.983) | 0.014 | 0.914 (0.848, 0.986) | 0.019 |
Medication during hospitalization | ||||
PCI/CABG | 1.058 (0.987, 1.133) | 0.111 | ||
Antiplatelet agent | 0.774 (0.679, 0.882) | < 0.001 | 0.806 (0.693, 0.937) | 0.020 |
ACEI/ARB | 1.096 (1.022, 1.174) | 0.010 | ||
Beta-blocker | 1.040 (0.965, 1.121) | 0.301 | ||
Statins | 0.842 (0.756, 0.937) | 0.002 | ||
Hypoglycemic agents | ||||
Alpha-glucosidase inhibitor | 1.198 (1.108, 1.296) | < 0.001 | ||
Metformin | 1.056 (0.954, 1.168) | 0.293 | ||
Sulfonylurea | 0.994 (0.876, 1.128) | 0.925 | ||
DPP-4i | 1.165 (0.437, 3.107) | 0.760 | ||
Insulin | 1.352 (1.208, 1.512) | < 0.001 | ||
Insulin sensitizer | 1.014 (0.814, 1.263) | 0.901 |